"XOMAD should be above $5.00 here."“Last week’s 1 – 15 reverse split is impacting the share price.”"Substantially oversold."“Current price is equal to about 20 cents pre-split.”“52 week high was $15.85 on a post split basis. Bottomed at $3.02 on Friday.”"Current market cap is only $63 million. Companies with no track record of product development and a similar drug in the pipeline are valued at many times what XOMA is currently."“GSK needs a replacement for Avandia. Potential suitor.”“Company is currently self-funded through the next 12 months with almost $100,000,000 in revenues.”"Buy it before the gap-up.""Partnership announcement takes it above $10.00."“Due diligence but do buy a few shares here.”
Bought a few shares of XOMAD today. It's also cheap here.
this is getting ready to run- hold tight-don't sell your shares till it hits $2.00 -then take your profits! Then buy it down to zero and sell everything at that point-You may get some light fixtures